CompletedNot Applicable

Role of Cryobiopsy in Diagnosis of Pleural Effusion

Egypt60 participantsStarted 2020-03-10

Plain-language summary

The purpose of this study is to evaluate the feasibility, size and quality of the specimens obtained by cryoprobe in comparison to those specimens obtained by flexible forceps during medical thoracoscopy in diagnosis of pleural effusion.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Transudative pleural effusion.
✕. Exudative pleural effusion less than one third of hemithorax.
✕. Presence of hemorrhagic diathesis (prothrombin concentration \<50% and platelet count \<80,000/mm 3).
✕. Poor performance state (ECOG performance status \>4) as recommended in BTS (British thoracic society) guidelines 2010.
✕. Sever uncontrollable cough, hypercapnia and sever respiratory distress.
✕. Fibrothorax, excessive pleural adhesion.

What they're measuring

comparison between pleural biopsy specimens obtained by flexible forceps with those obtained with cryoprobe during medical thoracoscopy in diagnosis of pleural effusion.

Timeframe: 12 months

Trial details

NCT IDNCT03828903

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-10

View on ClinicalTrials.gov More Pleural Effusion trials